Because HBV infection and replication can stimulate the NF-κB and p53-signaling pathways to promote the onset and development of lymphoma [11,18,19], the HBV infection status in vivo has serious effects on NHL treatment. Here, TP53 is linked to non-Hodgkin lymphoma.